Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids December 17, 2019
Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights November 13, 2019
Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides October 29, 2019
Ceapro to Present PGX Technology at the 3rd International Symposium on Pharmaceutical Engineering Research September 25, 2019
Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights August 28, 2019
Ceapro Announces Research Funding Award from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada for Joint Projects with McMaster University August 27, 2019
